Abyntek Biopharma S.L. is a Biotechnology company whose activities are based on the development, production and commercialisation of tailored antibodies and antigens (polyclonal rabbit and monoclonal mouse antibodies) and the commercialisation of catalogue antibodies.
In the research field, Abyntek focuses its RDI line on the development of new monoclonal antibody production technologies on the one hand, and on the development of diagnosis, prognosis and therapy systems for lung disease on the other.
All of Abyntek’s business activities are based on two fundamental values: qualified human capital and an adequate technological infrastructure, to ensure that the scientific community is guaranteed to receive a high quality service based on responsibility, closeness and constant communication.
Ainara Hernándo
Telephone No.: +34 94 4048080
E-mail: ainarahm@hotmail.com
Website: www.abyntek.com